Effect of brefelamide on HGF-induced survival of 1321N1 human astrocytoma cells
暂无分享,去创建一个
S. Mitazaki | Makoto Yoshida | S. Honma | S. Abe | T. Ishikawa | T. Shibuya | S. Takasaka
[1] F. Marincola,et al. Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma , 2011, Proceedings of the National Academy of Sciences.
[2] T. Suthiphongchai,et al. Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion. , 2010, World Journal of Gastroenterology.
[3] A. Wong,et al. c-Met overexpression contributes to the acquired apoptotic resistance of nonadherent ovarian cancer cells through a cross talk mediated by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1/2. , 2010, Neoplasia.
[4] J. Christensen,et al. PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells , 2009, BMC Cancer.
[5] N. Nakahata,et al. A reduction of epidermal growth factor receptor is involved in brefelamide-induced inhibition of phosphorylation of ERK in human astrocytoma cells. , 2009, European journal of pharmacology.
[6] J. Cardelli,et al. Inhibition of fatty acid synthase by luteolin post-transcriptionally down-regulates c-Met expression independent of proteosomal/lysosomal degradation , 2009, Molecular Cancer Therapeutics.
[7] R. Walikonis,et al. Hepatocyte growth factor and c-Met promote dendritic maturation during hippocampal neuron differentiation via the Akt pathway. , 2008, Cellular signalling.
[8] J. Menéndez,et al. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis , 2007, Nature Reviews Cancer.
[9] Y. Inoue,et al. Leucine stimulates HGF production by hepatic stellate cells through mTOR pathway. , 2007, Biochemical and biophysical research communications.
[10] N. Nakahata,et al. Thromboxane A2 receptor-mediated G12/13-dependent glial morphological change. , 2006, European journal of pharmacology.
[11] J. Laterra,et al. Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis. , 2005, Neuro-oncology.
[12] Jian Tajbakhsh,et al. Proteinase and growth factor alterations revealed by gene microarray analysis of human diabetic corneas. , 2005, Investigative ophthalmology & visual science.
[13] N. Nakahata,et al. Isolation and synthesis of a new aromatic compound, brefelamide, from dictyostelium cellular slime molds and its inhibitory effect on the proliferation of astrocytoma cells. , 2005, The Journal of organic chemistry.
[14] P. Comoglio,et al. Cancer therapy: can the challenge be MET? , 2005, Trends in molecular medicine.
[15] P. Wen,et al. Targeted molecular therapy of malignant gliomas , 2005, Current oncology reports.
[16] W. Birchmeier,et al. Met, metastasis, motility and more , 2003, Nature Reviews Molecular Cell Biology.
[17] R. Fields,et al. New insights into neuron-glia communication. , 2002, Science.
[18] B. Hemmings,et al. Ten years of protein kinase B signalling: a hard Akt to follow. , 2001, Trends in biochemical sciences.
[19] H. Dietz,et al. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression. , 1999, Journal of the National Cancer Institute.
[20] Y. Ohizumi,et al. Decrease in thromboxane A2 receptor expression by differentiation with dibutyryl cyclic AMP in 1321N1 human astrocytoma cells. , 1999, Prostaglandins & other lipid mediators.
[21] K. Matsumoto,et al. Emerging multipotent aspects of hepatocyte growth factor. , 1996, Journal of biochemistry.
[22] W. Birchmeier,et al. Hepatocyte growth factor/scatter factor induces a variety of tissue- specific morphogenic programs in epithelial cells , 1995, The Journal of cell biology.
[23] J. Sarkaria,et al. An orally bioavailable c-Met kinase inhibitor potently inhibits brain tumor malignancy and growth. , 2010, Anti-cancer agents in medicinal chemistry.
[24] E. Brown,et al. Transforming growth factor beta receptor family ligands inhibit hepatocyte growth factor synthesis and secretion from astrocytoma cells. , 2004, Brain research. Molecular brain research.
[25] H. Althaus,et al. Glial cells as targets and producers of neurotrophins. , 2000, International review of cytology.